BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20224408)

  • 1. Pleural fluid tests to identify complicated parapneumonic effusions.
    Porcel JM
    Curr Opin Pulm Med; 2010 Jul; 16(4):357-61. PubMed ID: 20224408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
    Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
    Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parapneumonic effusions and empyema.
    Light RW
    Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.
    Manuel Porcel J; Vives M; Esquerda A; Ruiz A
    Respir Med; 2006 May; 100(5):933-7. PubMed ID: 16253494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.
    Porcel JM; Bielsa S; Esquerda A; Ruiz-González A; Falguera M
    Eur J Intern Med; 2012 Jul; 23(5):447-50. PubMed ID: 22726374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of C-reactive protein in parapneumonic effusions.
    Skouras V; Boultadakis E; Nikoulis D; Polychronopoulos V; Daniil Z; Kalomenidis I; Gourgoulianis KI
    Respirology; 2012 Feb; 17(2):308-14. PubMed ID: 21995428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
    Castaño Vidriales JL; Amores Antequera C
    Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of measurement of interleukin-1ß and interleukin-8 in the diagnosis of complicated parapneumonic pleural effusions.
    San José ME; Ferreiro L; Soneira ME; González-Barcala FJ; Vázquez MC; Golpe A; Valdés L
    Am J Clin Pathol; 2014 Oct; 142(4):467-73. PubMed ID: 25239413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
    Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
    Lung; 2006; 184(3):141-5. PubMed ID: 16902838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
    Porcel JM; Vives M; Esquerda A
    Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleural effusions caused by infection.
    Varkey B
    Postgrad Med; 1986 Oct; 80(5):213-6, 219, 222-3. PubMed ID: 3763525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.
    Bishara J; Goldberg E; Ashkenazi S; Yuhas Y; Samra Z; Saute M; Shaked H
    Ann Thorac Surg; 2009 Jan; 87(1):251-4. PubMed ID: 19101307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural fluid parameters identifying complicated parapneumonic effusions.
    Jiménez Castro D; Díaz Nuevo G; Sueiro A; Muriel A; Pérez-Rodríguez E; Light RW
    Respiration; 2005; 72(4):357-64. PubMed ID: 16088277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
    Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
    Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of parapneumonic pleural effusions].
    Asensio de la Cruz O; Blanco González J; Moreno Galdó A; Pérez Frías J; Salcedo Posadas A; Sanz Borrell L;
    An Esp Pediatr; 2001 Mar; 54(3):272-82. PubMed ID: 11262257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.
    Heffner JE; Brown LK; Barbieri C; DeLeo JM
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1700-8. PubMed ID: 7767510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions.
    Bielsa S; Valencia H; Ruiz-González A; Esquerda A; Porcel JM
    Lung; 2014 Aug; 192(4):577-81. PubMed ID: 24913743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing length of hospital stay in patients with bacterial pleural effusion.
    Soriano T; Alegre J; Alemán C; Ruiz E; Vázquez A; Carrasco JL; Segura R; Ferrer A; Fernández de Sevilla T
    Respiration; 2005; 72(6):587-93. PubMed ID: 16106111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.